Similar IL-5, IL-3, and GM-CSF syntheses by eosinophils in the jejunal mucosa of patients with celiac disease and dermatitis herpetiformis

Clinical Immunology and Immunopathology

Volumn 88, Issue 1, 1998, Pages 14-21

  Desreumaux, Pierre ^a,b   Delaporte, Emmanuel ^a   Colombel, Jean Frédéric ^a   Capron, Monique ^b   Cortot, Antoine ^a   Janin, Anne ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Celiac disease; Cytokines; Dermatite herpetiformis; Eosinophils; T cells

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5;

ADULT; ARTICLE; CELIAC DISEASE; CELL ULTRASTRUCTURE; DERMATITIS HERPETIFORMIS; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; JEJUNUM; MALE; PRIORITY JOURNAL;

EID: 0031877178     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4494     Document Type: Article

References (42)

1. Marsh M. N., Ensari A., Morgan S. Evidence that gluten sensitivity is an immunologic disease. Curr. Opin. Gastroenterol. 9:1993;994-1000.
2. Marsh M. N. Gluten, Major histocompatibility complex, and the small intestine: A molecular and immunobiologic approach to the spectrum of gluten sensitivity ("Celiac Sprue"). Gastroenterology. 102:1992;330-354.
3. Hall R. P. III. Dermatitis herpetiformis. J. Invest. Dermatol. 99:1992;873-881.
4. Ahmed A. R., Yunis J. J., Marcus-Bagley D., Yunis E. J., Salazar M., Katz A. J., Awdeh Z., Alper C. A. Major histocompatibility complex susceptibility genes for dermatitis herpetiformis compared with those for gluten-sensitive enteropathy. J. Exp. Med. 178:1993;2067-2075.
5. Macdonald T. T. The role of activated T lymphocytes in gastrointestinal disease. Clin. Exp. Allergy. 20:1990;247-252.
6. Lionetti P., Breese E., Braegger C. P., Murch S. H., Taylor J., MacDonald T. T. T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology. 105:1993;373-381.
7. Marsh M. N., Hinde J. Inflammatory component of celiac sprue mucosa. Gastroenterology. 89:1985;92-101.
8. Colombel J. F., Torpier G., Janin A., Klein O., Cortot A., Capron M. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein. Gut. 33:1992;1190-1194.
9. Desreumaux P., Capron M. Eosinophils in allergic reactions. Curr. Opin. Immunol. 8:1996;790-795.
10. Yamaguchi Y., Suda T., Suda J., Eguchi M., Miura Y., Harada N., Tominaga A., Takatsu K. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:1988;43-56.
11. Yamaguchi Y., Hayashi Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J. Exp. Med. 167:1988;1737-1742.
12. Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:1988;219-224.
13. Saito H., Hatake K., Dvorak A. M., Leiferman K. M., Donnenberg A. D., Arai N., Ishizaka K., Ishizaka T. Selective differentiation and proliferation of hematopoietic cells induced by recombinant interleukins. Proc. Natl. Acad. Sci. USA. 85:1988;2288-2292.
14. Clutterbuck E. J., Hirst E. M. A., Sanderson C. J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cells: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood. 73:1989;1504-1512.
15. Roth J., Bendayan M., Carlemalm E., Villinger W., Garavito M. Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue. J. Histochem. Cytochem. 29:1981;663-671.
16. Marsh M. N. Studies of intestinal lymphoid tissue. XI. The immunopathology of cell-mediated reactions in gluten sensitivity and other enteropathies. Scanning Microscopy. 2:1988;1663-1684.
17. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J. Immunol. 123:1979;2925-2927.
18. Dubucquoi S., Janin A., Klein O., Desreumaux P., Quandalle P., Cortot A., Capron M., Colombel J. F. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut. 37:1995;242-246.
19. Hällgren R., Colombel J. F., Dahl R., Fredens K., Kruse A., Jacobsen N. O., Venge P., Rambaud J. C. Neutrophil and eosinophil involvement of the small bowel in patients with coeliac disease and crohn's disease: studies on the excretion rate and immunohistochemical localization of granulocytes constituents. Am. J. Med. 86:1989;56-64.
20. Desreumaux P., Brandt E., Gambiez L., Emilie D., Geboes K., Klein O., Ectors N., Cortot A., Capron M., Colombel J. F. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology. 113:1997;118-126.
21. Desreumaux P., Janin A., Colombel J. F., Prin L., Plumas J., Emilie D., Torpier G., Capron A., Capron M. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J. Exp. Med. 175:1992;293-296.
22. Dent L. A., Strath M., Mellor A. L., Sanderson C. J. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172:1990;1425-1431.
23. Nielsen K., Fogh L., Andersen S. Eosinophil response to migrating Ascaris suum larvae in normal and congenitally thymus-less mice. Acta Path. Microbiol. Immunol. Scand. 82:1974;919-925.
24. Marsh M. N., Loft D. E., Garner V. G., Gordon D. Time/dose responses of coeliac mucosae to graded oral challenges with Frazer's fraction III of gliadin. Eur. J. Gastroenterol. Hepatol. 4:1992;667-673.
25. Lavö B., Knutson L., Lööf L., Odlind B., Venge P., Hällgren R. Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. Am. J. Med. 87:1989;655-660.
26. Weller P. F. Roles of eosinophils in allergy. Curr. Opin. Immunol. 4:1992;782-787.
27. Kameyoshi Y., Dorschner A., Mallet A. I., Christophers E., Schroder J. M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:1992;587-592.
28. Ponath P. D., Qin S., Ringler D. J., Cark-Lewis I., Wuang J., Kassam N., Smith H., Shi X., Gonzalo J. A., Newman W., Gutierrez-Ramos J. C., Mackay C. R. Cloning of the human eosinophil chemoattractant, eotaxin. J. Clin. Invest. 97:1996;604-612.
29. Uguccioni M., Loetscher P., Forssmann U., Dewald B., Li H., Hensche Lima S. H., Li Y., Kreider B., Garotta G., Thelen M., Baggiolini M. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:1996;2379-2384.
30. Collins P. D., Marleau S., Griffiths-Johnson D. A., Jose P. J., Williams T. J. Cooperation between IL-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1995;1169-1174.
31. Mould A. W., Matthaei K. I., Young I. G., Foster P. S. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1997;1064-1071.
32. Rothenberg M. E., MacLean J. A., Pearlman E., Luster A. D., Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:1997;785-790.
33. MacLean J. A., Ownbey R., Luster A. D. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophilia. J. Exp. Med. 184:1996;1461-1469.
34. Abu Ghazaleh R., Fusisawa T., Mestecky J., Kyle A., Gleich G. J. IgA-induced eosinophil degranulation. J. Immunol. 142:1989;2393-23400.
35. Tomassini M., Tsicopoulos A., Tai P. C., Gruart V., Tonnel A. B., Prin L., Capron A., Capron M. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J. Allergy. Clin. Immunol. 88:1991;365-375.
36. Monteiro R. C., Hostoffer R. W., Cooper M. D., Bonner J. R., Gartland L., Kubagawa H. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J. Clin. Invest. 92:1993;1681-1685.
37. Lamkhioued B., Soussi Gounni A., Gruart V., Pierce A., Capron A., Capron M. Human eosinophils express a receptor for secretory component. Eur. J. Immunol. 25:1995;117-125.
38. Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C. J. Regulatory effect of cytokines on eosinophil degranulation. J. Immunol. 144:1990;642-646.
39. Dubucquoi S., Desreumaux P., Janin A., Goldman M., Tavernier J., Capron A., Capron M. Synthesis of interleukin-5 by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:1994;703-708.
40. Venge P. Human eosinophil granule proteins: Structure, function and release. Immunopharmacology of Eosinophils. 1993;Academic Press, London. p. 57-69.
41. Broide D. H., Paine M. M., Firestein G. S. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1992;1414-1424.
42. Van Leeuwen B. H., Martinson M. E., Webb G. C., Young I. G. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5 and GM-CSF genes, on human chromosome 5. Blood. 73:1989;1142-1148.